Study record

Serum MOTS-C Levels are Decreased in Obese Children and Associated with Vascular Endothelial Function

Luo YH, Xie L, Li JY et al. · Diabetes Metab Syndr Obes · 2023

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured serum MOTS-c by ELISA and peripheral endothelial function by reactive hyperemia index in children. Found lower serum MOTS-c and lower reactive hyperemia index in children with obesity than in healthy children, and reported that reactive hyperemia index was independently associated with body mass index, HDL cholesterol and MOTS-c, with a mediation analysis attributing a small share of the body-mass-index-to-reactive-hyperemia-index association to MOTS-c.

Limitations

Cross-sectional design cannot establish direction of effect; single-centre paediatric sample; mediation analysis accounted for only a small proportion of the association; no MeSH indexing or further covariate detail reported in the abstract.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedSerum MOTS-c and peripheral arterial tonometry in children with obesity and healthy children
PopulationChildren with obesity (mean age about 8 years) and healthy children of similar age
DesignCross-sectional case-control study
Sample size as reported443 children (225 with obesity, 218 healthy)
Control grouphealthy children of similar age
Route (data field only)Not reported
Endpoints measuredserum MOTS-c concentration; reactive hyperemia index; body mass index; HDL cholesterol
Pathways measuredOther
Research areasMetabolic · Cardiovascular
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Adequate
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.